Stay updated on LN-144 in Metastatic Melanoma Brain Clinical Trial
Sign up to get notified when there's something new on the LN-144 in Metastatic Melanoma Brain Clinical Trial page.

Latest updates to the LN-144 in Metastatic Melanoma Brain Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and outdated notices—including v3.4.1—were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a government funding notice about possible delays and updated the site revision to v3.4.1, replacing the previous v3.4.0 note. These changes do not affect the study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedMinor UI and versioning updates were made to the study page, including a glossary toggle and changes to QC update date labels. The page revision was updated to v3.4.0 (from v3.3.4) and No FEAR Act data labeling was adjusted.SummaryDifference0.3%

- Check35 days agoChange DetectedThe site version label was updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded the Locations section with New York as a study location and updated the page to revision v3.3.3; the old 'New York Locations' label and the 'HHS Vulnerability Disclosure' link were removed.SummaryDifference0.3%

- Check85 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2 on the page. No study content, layout, or functionality appears to be affected.SummaryDifference0.1%

Stay in the know with updates to LN-144 in Metastatic Melanoma Brain Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-144 in Metastatic Melanoma Brain Clinical Trial page.